162 related articles for article (PubMed ID: 28566532)
1. Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms.
Valente R; Hayes AJ; Haugvik SP; Hedenström P; Siuka D; Korsæth E; Kämmerer D; Robinson SM; Maisonneuve P; Delle Fave G; Lindkvist B; Capurso G
Endocr Relat Cancer; 2017 Aug; 24(8):405-414. PubMed ID: 28566532
[TBL] [Abstract][Full Text] [Related]
2. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
Haugvik SP; Hedenström P; Korsæth E; Valente R; Hayes A; Siuka D; Maisonneuve P; Gladhaug IP; Lindkvist B; Capurso G
Neuroendocrinology; 2015; 101(2):133-42. PubMed ID: 25613442
[TBL] [Abstract][Full Text] [Related]
3. Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms.
Zhuge X; Wang Y; Chen X; Guo C
Front Endocrinol (Lausanne); 2020; 11():615082. PubMed ID: 33424776
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study.
Ben Q; Zhong J; Fei J; Chen H; Yv L; Tan J; Yuan Y
Sci Rep; 2016 Oct; 6():36073. PubMed ID: 27782199
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.
Muscogiuri G; Altieri B; Albertelli M; Dotto A; Modica R; Barrea L; Fanciulli G; Feola T; Baldelli R; Ruggeri RM; Gallo M; Guarnotta V; Malandrino P; Messina E; Venneri MA; Giannetta E; Ferone D; Colao A; Faggiano A;
Endocrine; 2020 Aug; 69(2):441-450. PubMed ID: 32468269
[TBL] [Abstract][Full Text] [Related]
6. Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study.
Rinzivillo M; Capurso G; Campana D; Fazio N; Panzuto F; Spada F; Cicchese N; Partelli S; Tomassetti P; Falconi M; Delle Fave G
Neuroendocrinology; 2016; 103(5):531-7. PubMed ID: 26356731
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.
Hassan MM; Phan A; Li D; Dagohoy CG; Leary C; Yao JC
Int J Cancer; 2008 Aug; 123(4):867-73. PubMed ID: 18491401
[TBL] [Abstract][Full Text] [Related]
9. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients.
Capurso G; Falconi M; Panzuto F; Rinzivillo M; Boninsegna L; Bettini R; Corleto V; Borgia P; Pederzoli P; Scarpa A; Delle Fave G
Am J Gastroenterol; 2009 Dec; 104(12):3034-41. PubMed ID: 19690522
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.
Cheng Y; Zhan H; Wang L; Xu J; Zhang G; Zhang Z; Hu S
Front Med; 2016 Dec; 10(4):444-450. PubMed ID: 27757796
[TBL] [Abstract][Full Text] [Related]
12. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
[TBL] [Abstract][Full Text] [Related]
13. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer.
Silverman DT; Schiffman M; Everhart J; Goldstein A; Lillemoe KD; Swanson GM; Schwartz AG; Brown LM; Greenberg RS; Schoenberg JB; Pottern LM; Hoover RN; Fraumeni JF
Br J Cancer; 1999 Aug; 80(11):1830-7. PubMed ID: 10468306
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study.
Halfdanarson TR; Bamlet WR; McWilliams RR; Hobday TJ; Burch PA; Rabe KG; Petersen GM
Pancreas; 2014 Nov; 43(8):1219-22. PubMed ID: 25291526
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
[No Abstract] [Full Text] [Related]
17. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
18. The association between jaundice and poorly differentiated pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%).
Liu Y; Wang J; Zhou H; Wei Z; Wang J; Wang Z; Chen X
BMC Gastroenterol; 2023 Dec; 23(1):436. PubMed ID: 38087239
[TBL] [Abstract][Full Text] [Related]
19. The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study.
Wang C; Lin T; Chen X; Cui W; Guo C; Wang Z; Chen X
Cancer Biomark; 2023; 36(4):279-286. PubMed ID: 36938727
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Pancreatic Cancer in China: A Multicenter Case-Control Study.
Zheng Z; Zheng R; He Y; Sun X; Wang N; Chen T; Chen W
J Epidemiol; 2016; 26(2):64-70. PubMed ID: 26441209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
